Sign in to follow
Search Results

0 results for 'Young Conaway Stargatt Taylor'

You can use to get even better search results
New Antitrust Complaint Against Genentech Raises Ghost of 2007 Supreme Court Loss
Publication Date: 2011-02-24
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Human Genome Science and its Simpson Thacher lawyers have filed a juicy complaint against Genentech, alleging that the rival biotech conspired with CellTech to lock up a monopoly on the therapeutic antibody process until 2018. But HGS isn't the first plaintiff to make such claims.

March 30, 1999 |

Settlement OK'd in Suits Over 3-D Geophysical Aquisition

A Delaware Chancery judge has approved 3-D Geophysical Inc.'s settlement of a shareholder suit opposing Western Atlas Inc.'s $114 million acquisition of the oil services company last year. Also approved was $150,000 in fees and expenses for the plaintiffs' lawyers. Western acquired 3-D in May 1998. The suit was settled in exchange for more information about 3-D's operations and a $1.5 million cut of the transaction's proposed $5.5 million breakup fee.
2 minute read
MLB Wants Dodgers to Cover League's Legal Costs in Team's Bankruptcy
Publication Date: 2012-04-06
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

The settlement between Major League Baseball and Los Angeles Dodgers owner Frank McCourt didn't resolve all their differences: Baseball Commissioner Allan "Bud" Selig now wants the league's $7.6 million in legal bills and costs paid for by the team before it emerges from bankruptcy.

Proskauer Rose Helps Take-Two Interactive out of Two Jams in One Week
Publication Date: 2009-04-06
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Proskauer, led by partner Sarah Gold, has helped Take-Two Interactive Software settle both a shareholder class action related to a spurned buyout offer from Electronic Arts and government investigations into stock options backdating.

Barnes & Noble Poison Pill Trial Kicks Off with Testimony by Mogul Ron Burkle and Commentary by Vice-Chancellor Leo Strine
Publication Date: 2010-07-08
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Thanks to Courtroom View's live video stream of Burkle's closely-watched challenge to Barnes & Noble's poison pill, we got to see the vice-chancellor engage in some straight-talking colloquies with the billionaire investor.

August 17, 1999 |

Iridium in the Red and Under Fire

Satellite-phone company Iridium LLC has joined the parade of billion-dollar companies filing for bankruptcy court protection in Delaware, while dissident noteholders filed an involuntary petition against the company in New York. Iridium filed its Chapter 11 petition after its bondholders and its biggest investor, Motorola Inc., couldn't agree on a plan that would allow the cash-strapped satellite-telephone company to repay its debts.
2 minute read
Big Day for the Brands: Generic Pharma Companies Lose Patent Challenges to Blockbuster BMS, Lilly Drugs
Publication Date: 2010-11-16
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Billions of dollars of revenue were at stake in challenges to an antipsychotic co-marketed by Bristol-Myers and a Lilly lung cancer treatment. But courts in Delaware and New Jersey upheld the brands' patents.

In Stent Patent War, Boston Scientific Caves (Again), Agrees to Pay Johnson & Johnson $1.725 Billion to Settle Three Cases
Publication Date: 2010-02-01
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

J&J's lawyers from Patterson Belknap were all set to go after Boston Scientific for damages and willfulness at trial in Delaware, but Boston Scientific's new management is in a settling mood.

November 19, 2007 |

The Firm Reports

67 minute read
Sandra Goldstein of Cravath, Swaine & Moore
Publication Date: 2010-08-19
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Who knows what will happen in billionaire Ron Burkle's proxy contest for three Barnes & Noble board seats. But as lead counsel for B&N in the Delaware trial to determine the legality of the bookseller's poison pill, Goldstein helped assure that Burkle goes into the contest owning less than 20 percent of the company's shares.

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources